Diagnostics lab picks Valkit.ai to modernize validation
A leading U.S. clinical diagnostics laboratory with more than $700 million in annual revenue has chosen Valkit.ai to move its validation program from document-heavy workflows to connected digital assurance. The shift puts requirements, risk, testing, evidence and approvals in one platform as labs face faster turnaround demands and strict regulatory scrutiny.
Why it matters: - The move reflects a broader shift in regulated labs from document-based validation to digital assurance built around traceability and risk. - For a diagnostics lab, faster validation can support speed, accuracy and inspection readiness without weakening oversight. - The decision also signals that AI-assisted tools are gaining traction in GxP environments, as long as qualified people keep final decision-making authority.
What happened: - Valkit.ai announced that a leading U.S. clinical diagnostics laboratory organization with more than $700 million in annual revenue selected the Valkit platform. - The lab will use Valkit to modernize its validation program. - The organization is moving away from document-centric validation toward a structured, risk-based digital approach.
The details: - Requirements, risks, test execution, evidence and approvals will live in one connected platform. - Traceability will be built into the validation process from the start. - Valkit’s organization model lets license holders structure and control validation workspaces to match their own quality procedures. - The platform is designed to support company-wide oversight and team-level accountability without forcing one fixed structure on every team. - Validated content, templates and assets can be reused across systems and projects. - Valkit’s AI can propose, draft and flag items, while qualified people remain responsible for interpretation, risk acceptance and release decisions. - Stephen Ferrell, co-founder and chief product officer at Valkit.ai, said diagnostics laboratories operate under speed, accuracy and regulatory pressure at the same time. - Ferrell said the company wants to help make validation faster and more defensible while keeping qualified people in control of every decision. - The customer joins a broader group of life-sciences, laboratory and manufacturing organizations using Valkit for computerized system validation, Computer Software Assurance and equipment and laboratory assurance. - Valkit.ai describes itself as a life-sciences compliance software company. - The company says its platform helps regulated organizations replace document-heavy validation with connected, risk-based digital assurance.
Between the lines: - The customer choice suggests large regulated organizations are becoming more willing to replace paper-shaped digital processes with systems that connect evidence, risk and approvals in one workflow. - The emphasis on reuse points to a practical cost and speed benefit, not just a compliance upgrade. - The messaging around human control shows that AI adoption in regulated work still depends on clear accountability, not automation alone.
What's next: - Organizations interested in modernizing their validation programs can request a demo at Valkit.ai. - Valkit.ai says more life-sciences and manufacturing customers are adopting its platform for validation and assurance use cases. - The company is positioning digital assurance as a standard operating model rather than an experiment.
The bottom line: - A large diagnostics lab is betting that validation can be both faster and more defensible when risk, evidence and approvals sit in one governed digital system.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
US Environmental News Reporter
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.